Predict your next investment

Medicortex Finland company logo
HEALTHCARE | Disease Diagnosis
medicortex.fi

See what CB Insights has to offer

Founded Year

2014

Stage

Unattributed | Alive

Total Raised

$1.94M

Last Raised

$590K | 2 mos ago

About Medicortex Finland

Medicortex Finland is dedicated to improving the diagnosis, treatment and prevention of acute neurodegenerative conditions and is currently focused on developing a multiplex treatment for traumatic brain injury.

Medicortex Finland Headquarter Location

Itäinen Pitkäkatu 4 4th Floor

Turku, 20520,

Finland

+358 40 0870366

Latest Medicortex Finland News

Medicortex Closes Half Million Euro Pre-IPO Funding Round

Sep 29, 2021

Medicortex Closes Half Million Euro Pre-IPO Funding Round Medicortex Finland Oy , a Turku, Finland-based biotechnology company developing diagnostic tests for brain injury, closed a pre-IPO share issue round of half million euro. Existing shareholders and new investors participated in the round. The capital will allow the company to proceed to the next phase in the process of Initial Public Offering (IPO) expected to take place in 2022, in parallel to the development of its lead product candidate. Led by Adrian Harel CEO, Medicortex Finland Oy is a biotechnology company dedicated to improving the diagnostics and treatment of Traumatic Brain Injury (TBI). The company’s current focus is to develop biomarker diagnostics to evaluate mild TBI and concussion. Its first generation product, ProbTBITM, is a disposable strip test for rapid detection of concussion from urine or saliva, both for professional and lay use. Göteborg Corporate Finance (GCF) acted as financial advisor to Medicortex during the pre-IPO and has also been appointed as financial advisor for the upcoming IPO and dual listing at Nasdaq First North Helsinki and Stockholm. FinSMEs

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Medicortex Finland

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Medicortex Finland is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

7,884 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

B

Biopharmaceuticals

5,882 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Medicortex Finland Patents

Medicortex Finland has filed 3 patents.

The 3 most popular patent topics include:

  • Medical signs
  • Neuropsychological tests
  • Neurotrauma
patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/2/2015

5/22/2018

Neurotrauma, Amines, Neuropsychological tests, Medical signs, Neuropsychology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

10/2/2015

00/00/0000

00/00/0000

Grant Date

5/22/2018

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Related Topics

Neurotrauma, Amines, Neuropsychological tests, Medical signs, Neuropsychology

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.